A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus (EXSCEL)

Grant

Date/time Interval

  • April 1, 2010 - August 31, 2016
  • Total Award Amount

  • 127260.00
  • Direct Costs

  • 100998.00
  • Sponsor Award Id

  • BCB 109
  • Contributor

  • Oparil, Suzanne   Principal Investigator